News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
Announcements
June 3, 2024
Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing
Announcements
May 22, 2024
Repligen to Present at Upcoming June Investor Conferences
Announcements
May 7, 2024
Repligen Corporation to Present at Upcoming May Investor Conferences
Announcements
March 19, 2024
Repligen Appoints Maggie A. Pax to Board of Directors
Announcements
December 19, 2023
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
Announcements
December 7, 2023
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements
Announcements
November 14, 2023
Repligen Announces Publication of the Company’s 2022 Sustainability Report
Announcements
November 14, 2023
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
Announcements
November 7, 2023
Repligen Corporation to Present at Upcoming Investor Conferences
Announcements
November 2, 2023
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
Announcements
October 2, 2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
Announcements
September 26, 2023